Segment Information (Tables)

3 Months Ended

Sep. 27, 2014

Schedule of Segment Reporting Information, by Segment [Table Text Block]



	Three Months Ended
	September 27, 2014
	Net Sales		Operating Income (Loss)			Amortization of Intangibles		Total Assets
Consumer Healthcare	$	493.3	$	65.3		$	8.6	$	3,828.0
Nutritionals	125.3		8.6			7.2		1,072.6
Rx Pharmaceuticals	194.5		64.7			17.0		2,509.1
API	24.8		7.1			0.5		251.2
Specialty Sciences	91.9		14.9			72.8		6,023.0
Other	21.7		0.9			0.4		97.1
Unallocated expenses	—		(24.3		)	—		—
Total	$	951.5	$	137.2		$	106.5	$	13,781.0

	Three Months Ended
	September 28, 2013
	Net Sales		Operating Income (Loss)			Amortization of Intangibles		Total Assets
Consumer Healthcare	$	538.5	$	89.9		$	5.3	$	2,508.6
Nutritionals	129.0		7.7			7.4		930.7
Rx Pharmaceuticals	203.6		83.1			16.2		1,669.0
API	43.2		22.4			0.5		295.2
Specialty Sciences	—		—			—		—
Other	19.1		1.2			0.4		105.3
Unallocated expenses	—		(24.6		)	—		—
Total	$	933.4	$	179.7		$	29.8	$	5,508.8

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details